![IMPROVED SURVIVAL IN MYELOFIBROSIS PATIENTS RECEIVING RUXOLITINIB.... EHA Library. Gavriilaki E. Jun 9 2021; 324976 IMPROVED SURVIVAL IN MYELOFIBROSIS PATIENTS RECEIVING RUXOLITINIB.... EHA Library. Gavriilaki E. Jun 9 2021; 324976](https://library.ehaweb.org/image/abstracts/eha_2021/EHA-1827.png)
IMPROVED SURVIVAL IN MYELOFIBROSIS PATIENTS RECEIVING RUXOLITINIB.... EHA Library. Gavriilaki E. Jun 9 2021; 324976
![The 46th Annual Meeting of the European Society for Blood and Marrow Transplantation: Physicians Poster Session (P001-P706) | Bone Marrow Transplantation The 46th Annual Meeting of the European Society for Blood and Marrow Transplantation: Physicians Poster Session (P001-P706) | Bone Marrow Transplantation](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41409-020-01120-w/MediaObjects/41409_2020_1120_Figa_HTML.png)
The 46th Annual Meeting of the European Society for Blood and Marrow Transplantation: Physicians Poster Session (P001-P706) | Bone Marrow Transplantation
![Case study of betibeglogene autotemcel gene therapy in an adult Greek patient with transfusion‐dependent β‐thalassaemia of a severe genotype - Constantinou - - British Journal of Haematology - Wiley Online Library Case study of betibeglogene autotemcel gene therapy in an adult Greek patient with transfusion‐dependent β‐thalassaemia of a severe genotype - Constantinou - - British Journal of Haematology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/e809c87d-d133-4c54-808c-894e944fa13b/bjh.17965.fp.png)
Case study of betibeglogene autotemcel gene therapy in an adult Greek patient with transfusion‐dependent β‐thalassaemia of a severe genotype - Constantinou - - British Journal of Haematology - Wiley Online Library
![Patient risk stratification and tailored clinical management of post‐transplant CMV‐, EBV‐, and BKV‐infections by monitoring virus‐specific T‐cell immunity - Papadopoulou - - eJHaem - Wiley Online Library Patient risk stratification and tailored clinical management of post‐transplant CMV‐, EBV‐, and BKV‐infections by monitoring virus‐specific T‐cell immunity - Papadopoulou - - eJHaem - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/faef262d-3c99-49e7-b849-edf16f278884/jha2175-fig-0003-m.jpg)
Patient risk stratification and tailored clinical management of post‐transplant CMV‐, EBV‐, and BKV‐infections by monitoring virus‐specific T‐cell immunity - Papadopoulou - - eJHaem - Wiley Online Library
Skewing of the T-cell receptor repertoire in patients receiving rituximab after allogeneic hematopoietic cell transplantation: what lies beneath?: Leukemia & Lymphoma: Vol 60, No 7
![Patient risk stratification and tailored clinical management of post‐transplant CMV‐, EBV‐, and BKV‐infections by monitoring virus‐specific T‐cell immunity - Papadopoulou - - eJHaem - Wiley Online Library Patient risk stratification and tailored clinical management of post‐transplant CMV‐, EBV‐, and BKV‐infections by monitoring virus‐specific T‐cell immunity - Papadopoulou - - eJHaem - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/a2637b1e-4381-496a-be8e-5b1a655fc537/jha2175-fig-0002-m.jpg)
Patient risk stratification and tailored clinical management of post‐transplant CMV‐, EBV‐, and BKV‐infections by monitoring virus‐specific T‐cell immunity - Papadopoulou - - eJHaem - Wiley Online Library
![THE IMPACT OF TREATMENT WITH BRENTUXIMAB VEDOTIN ON OVERALL.... EHA Library. Tsirigotis P. Jun 23 2017; 181567 THE IMPACT OF TREATMENT WITH BRENTUXIMAB VEDOTIN ON OVERALL.... EHA Library. Tsirigotis P. Jun 23 2017; 181567](http://www.multiwebcast.com/image/abstract/eha_2017/EHA-2179.jpg)
THE IMPACT OF TREATMENT WITH BRENTUXIMAB VEDOTIN ON OVERALL.... EHA Library. Tsirigotis P. Jun 23 2017; 181567
![PDF) Patient risk stratification and tailored clinical management of post‐transplant CMV‐, EBV‐, and BKV‐infections by monitoring virus‐specific T‐cell immunity PDF) Patient risk stratification and tailored clinical management of post‐transplant CMV‐, EBV‐, and BKV‐infections by monitoring virus‐specific T‐cell immunity](https://i1.rgstatic.net/publication/352060578_Patient_risk_stratification_and_tailored_clinical_management_of_post-transplant_CMV-_EBV-_and_BKV-infections_by_monitoring_virus-specific_T-cell_immunity/links/60b785a092851cde884dbc16/largepreview.png)
PDF) Patient risk stratification and tailored clinical management of post‐transplant CMV‐, EBV‐, and BKV‐infections by monitoring virus‐specific T‐cell immunity
![PDF) Allografted Recipients Immunized Against Hepatitis B Virus are at High Risk of Gradual Surface Antibody (HbsAb) Disappearance Post Transplant, Regardless of Adoptive Immunity Transfer PDF) Allografted Recipients Immunized Against Hepatitis B Virus are at High Risk of Gradual Surface Antibody (HbsAb) Disappearance Post Transplant, Regardless of Adoptive Immunity Transfer](https://i1.rgstatic.net/publication/6141628_Allografted_Recipients_Immunized_Against_Hepatitis_B_Virus_are_at_High_Risk_of_Gradual_Surface_Antibody_HbsAb_Disappearance_Post_Transplant_Regardless_of_Adoptive_Immunity_Transfer/links/5612a1c908ae4f0b651592e2/largepreview.png)
PDF) Allografted Recipients Immunized Against Hepatitis B Virus are at High Risk of Gradual Surface Antibody (HbsAb) Disappearance Post Transplant, Regardless of Adoptive Immunity Transfer
![Frontiers | Risk Factors and Outcomes of Klebsiella pneumoniae Infection Before and After Allogeneic Hematopoietic Cell Transplantation | Medicine Frontiers | Risk Factors and Outcomes of Klebsiella pneumoniae Infection Before and After Allogeneic Hematopoietic Cell Transplantation | Medicine](https://www.frontiersin.org/files/MyHome%20Article%20Library/608165/608165_Thumb_400.jpg)